July 28, 2014 at 12:11PM FDA Provides Equine Veterinarians with Important Information about TILDREN and OSPHOS for Navicular Syndrome in Horses

In the first half of 2014, FDA’s Center for Veterinary Medicine approved two new equine drugs—TILDREN manufactured by Ceva Sante Animale and OSPHOS manufactured by Dechra, Ltd.—intended to control the clinical signs of navicular syndrome, a common cause of forelimb lameness in horses.



via What's New: Animal & Veterinary http://ift.tt/1zlre4M